OpenVSafe by OpenVAERS
Search V-safe

DUR-29746-35658

2 vaccinations 6 coded responses 15 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
757 / TX
Registered
2020-12-22
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · Abdominal pain
    Adult check-in
  7. 2021-01-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  9. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain
    Adult check-in
  10. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness, Abdominal pain
    Adult check-in
  11. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-26
    Survey response — day 14, dose 2
    MedDRA: Pain — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Generalized body aches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-26
    Report sent to call center — day 14, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-02-02
    Survey response — day 21, dose 2
    MedDRA: C-reactive protein, C-reactive protein increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Elevated CRP
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-02
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-02-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-16
    Survey response — day 35, dose 2
    MedDRA: Inflammatory marker increased, Lymphadenopathy, Mammogram abnormal, Medical counselling, Tumour marker increased — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Swollen lymph nodes right breast;,abnormal mammogram. Have elevated inflammation/cancer markers in lab results. Not sure of cause yet. To see hematologist · Healthcare visit (other): Hematologist referral; breast ultrasound
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-16
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-02-25
    Survey response — day 42, dose 2
    MedDRA: Fatigue, Malaise, Nausea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Extrema fatigue, náusea, a sense of general malaise
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-16
    Survey response — 3 months, dose 2
    MedDRA: Arthralgia, Immunoglobulins increased, Office visit, Pelvic pain — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Severe joint and pelvis pain. Elevated immunoglobin protein. Now a patient at Texas Oncology seeing Hematologist.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-16
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-06-03
  23. 2022-01-12
    Survey response — 12 months, dose 2
    MedDRA: Hypoglycaemia, Monoclonal immunoglobulin present — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Hypoglycemia, IgA Iambda monoclonal band present Fingerstick glucose and venous glucose do not match by more than 20-30
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-01-12
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  25. 2022-01-13
  26. 2022-01-18

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech

Call center

5 call center cases

5 unsuccessful

See the call center timeline

Free text

Release 2 — day 14, dose 2

2021-01-26

Symptoms: Generalized body aches

Release 3 — day 21, dose 2

2021-02-02

Symptoms: Elevated CRP

Release 4 — day 35, dose 2

2021-02-16

Symptoms: Swollen lymph nodes right breast;,abnormal mammogram. Have elevated inflammation/cancer markers in lab results. Not sure of cause yet. To see hematologist
Healthcare visit (other): Hematologist referral; breast ultrasound

Release 4 — day 42, dose 2

2021-02-25

Symptoms: Extrema fatigue, náusea, a sense of general malaise

Release 7 — 3 months, dose 2

2021-04-16

Symptoms: Severe joint and pelvis pain. Elevated immunoglobin protein. Now a patient at Texas Oncology seeing Hematologist.

Release 10 — 12 months, dose 2

2022-01-12

Symptoms: Hypoglycemia, IgA Iambda monoclonal band present Fingerstick glucose and venous glucose do not match by more than 20-30

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
HCVOUltrasound breast ○ ○ ○
SDArthralgia ✓ ✓ ✓
SDC-reactive protein ○ ✓ ○
SDC-reactive protein increased ✓ ○ ✓
SDFatigue ✓ ✓ ✓
SDHypoglycaemia · · ✓
SDImmunoglobulins increased · · ✓
SDInflammatory marker increased ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDMalaise ✓ ✓ ✓
SDMammogram abnormal ✓ ✓ ✓
SDMonoclonal immunoglobulin present · · ✓
SDNausea ✓ ✓ ✓
SDOffice visit · · ✓
SDPain ✓ ✓ ✓
SDPelvic pain ✓ ✓ ✓
SDTumour marker increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release